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ABSTRACT  
Silica nanocapsules have attracted tremendous interest for encapsulation, protection and controlled 
release of various cargoes due to their unique hierarchical core–shell structure. However, it 
remains challenging to synthesize silica nanocapsules having high cargo-loading capacity and 
cargo-protection capability without compromising process simplicity and biocompatibility 
properties. Here, we synthesized oil-core silica-shell nanocapsules under environmentally friendly 
conditions by a novel emulsion and biomimetic dual-templating approach using a dual-functional 
protein, in lieu of petrochemical surfactants, thus avoiding the necessities for the removal of toxic 
components. A light- and pH-sensitive compound can be facilely encapsulated in the silica 
nanocapsules with the encapsulation efficiency of nearly 100%. Release of the encapsulated active 
from the nanocapsules was not shown an indication of undesired burst release. Instead, the release 
can be tuned by controlling the silica-shell thicknesses i.e., 40 and 77 nm from which the cargo 
released at 42.0 and 31.3% of the initial amount after 32 days, respectively. The release kinetics 
were fitted well to Higuchi model, enabling the possibility of the prediction of release kinetics as 
a function of shell thickness thus achieving design-for-purpose silica nanocapsules. Furthermore, 
the nanocapsules showed excellent alkaline- and sunlight-shielding protective efficacies which 
resulted in significantly prolonged half-life of the sensitive cargo. Our biomimetic silica 
nanocapsules provide a nanocarrier platform for applications that demand process scalability, 
sustainability and biocompatibility coupled with unique cargo-protection and controlled-release 
properties.  
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INTRODUCTION 
In the past decades, a wide variety of nanomaterials has been developed as nanocarriers for 
encapsulation and release of various active ingredients for applications ranging from 
pharmaceutical and nutraceutical to agricultural and personal care.1-3 Ideally, these nanomaterials 
should facilitate high loading capacity with controllable release and protection as many actives 
(e.g., therapeutics,4 imaging agents,5 nutrients,6 agrochemicals,7 and fragrance8) are sensitive to 
local environments (e.g., heat, light, pH) and hence prone to undergo degradation. However, it 
remains challenging to encapsulate and deliver these active agents while maintaining their 
stabilities, hence functionalities, for specific applications. A lot of efforts has been dedicated to 
develop new strategies for the design and synthesis of various types of nanomaterials based on 
polymer,9-11 lipid,12-14 and inorganic15-17 materials to protect and release such actives. Among 
them, inorganic silica nanomaterials have attracted significant interest due to their robust 
properties such as being mechanically strong, chemically stable, and relatively biocompatible.18-19  
Inorganic silica nanocapsules are promising as nanocarriers owing to their unique core–shell 
architecture.20 The core retains the actives and provides high loading capacity, while the shell 
protects the actives from the surrounding environment and acts as a diffusion barrier that controls 
release of the encapsulated actives. Templating methods have been widely utilized to synthesize 
silica nanocapsules using either hard (i.e., solid nanoparticles21-22) or soft (i.e., emulsion droplets23-
24 and gas bubbles25-26) templates. These approaches variously involve the use of chemical 
surfactants, organic solvents and template materials that are toxic, thus requiring tedious 
monitoring procedures for ensuring their complete removal down to the level that can be regarded 
as environmentally safe. Additionally, extreme pH and elevated temperature typically used during 
silica formation are obviously not suitable when sensitive active agents aforementioned are 
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encapsulated prior to the silica formation. Although an active can be post-loaded into the prepared 
silica nanocapsules, these strategies are time consuming and often result in low loading capacity 
and initial burst release due to the adsorbed active present on the nanocapsules’ surfaces. New 
methods for synthesizing silica nanocapsules for the encapsulation of sensitive materials using 
components and processes that are biocompatible and environmentally safe are urgently needed. 
Inspired by Nature, biomimetic templating methods have emerged as relatively new approaches 
to synthesize silica-based nanocarriers owing to the abilities of mineralizing biomolecules to 
recognize, interact with, and direct the nucleation and growth of silica under physiological 
conditions.27-31 For example, Jakhmola et al. synthesized oil-core silica-shell nanocapsules thereby 
using a layer-by-layer assembly method in which oppositely charged biomolecules were 
alternately deposited on a nanoemulsion template followed by silica mineralization.32 Erni et al. 
reported the synthesis of silica capsules having a diameter at a scale of hundreds of micrometers 
by silicification of cross-linked coacervate of gelatin and Acacia gum around oil droplets.33 
Recently, we developed a novel emulsion and biomimetic dual-templating technology to 
synthesize silica nanocapsules.24 This technology is based on the rational design of dual-functional 
peptides24 or proteins34 in lieu of chemical surfactants. The designed biomolecules are capable of 
stabilizing pharmaceutically-grade oil droplets (emulsification functionality) and concurrently 
inducing the formation silica shells (biomimetic-silicification functionality) at near-neutral pH and 
room temperature without the use of toxic organic solvents,24, 34 thus eliminating adverse 
environmental effects.35-36 In addition, encapsulation of an active is facile through its direct 
dissolution in the oil core prior to the silica-shell formation, enabling high encapsulation efficiency 
and avoiding initial burst release. More importantly, the bifunctional proteins can be produced via 
a simple and cheap engineered bioprocess,37 thus paving a pathway for large-scale economic 
Page 4 of 29
ACS Paragon Plus Environment
Langmuir
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 5 
production where cost is a competitive driver. While the bioenabled synthesis of silica 
nanocapsules has been described, release kinetics of an encapsulated active from silica 
nanocapsules as well as their capability of protecting the active under various conditions have not 
been studied  
In this work, the performances of silica nanocapsules to encapsulate, protect and release a 
sensitive cargo were systematically investigated to better understand their stability, release 
mechanisms and kinetics under different conditions. Fipronil, that is sensitive to light and pH, was 
used as a model active ingredient. Fipronil is an agrochemical that has been applied, for instance, 
in rice paddy fields38 which essentially expose it to both sunlight and soil acidity/alkalinity. Silica 
nanocapsules with two shell thicknesses were synthesized and used as nanocarriers for fipronil to 
study its encapsulation and sustained release, as well as its protective efficacies against simulated 
sunlight and different pHs. This study will provide a rational basis for designing and synthesizing 
novel and rational nanocarriers with desirable properties for controlled release. 
EXPERIMENTAL SECTION 
Materials. Miglyol 812 (Caesar & Loretz GmbH, Hilden, Germany) was purified using heat-
treated silica gel (Sigma-Aldrich Pty Ltd, Castle Hill, Australia) before use. The dual-functional 
protein D4S2 having an amino acid sequence of M(DPSMKQLADSLHQLARQVSRLEHA)4 
EPSRKKRKKRKKRKKGGGY and a theoretical molecular weight (MW) of 13299.3 g/mol was 
produced in our lab through recombinant gene expression using microbial cell factory34 and then 
purified by an engineered bioprocess.37 Fipronil (C12H4Cl2F6N4OS, MW 437.15 g/mol) was of 
analytical grade and was kindly provided by Accensi Pty Ltd (Narangba, Australia). Water having 
>18.2 MΩ cm resistivity was produced from a Milli-Q system with a 0.22 μm filter (Merck 
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 6 
Millipore, Bayswater, Australia). Other chemicals were of analytical grade obtained from either 
Merck or Sigma-Aldrich and used as received unless stated otherwise. 
Synthesis and Characterization. Miglyol 812 oil containing fipronil (10 g/L) was added to 
the D4S2 solution (1.53 g/L) in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
buffer (25 mM, pH 7.5) at a volume ratio of 1 to 9. Then the mixture was homogenized using an 
ultrasonicator (Branson Sonifier 450, Branson Ultrasonics, Danbury, CT) for four 30 s bursts at 
40 W and interspersed in an ice bath for 60 s to form nanoemulsions. The nanoemulsions were 
diluted 5 times (the final concentration of fipronil is 200 µg/mL) and then mixed with a silica 
precursor tetraethoxysilane (TEOS) at a concentration of 40 or 160 mM under stirring at room 
temperature for 24 h to form fipronil-loaded silica nanocapsules having two different silica-shell 
thicknesses. The fipronil-loaded silica nanocapsules were collected by centrifugation (10,000 g, 5 
min), and washed twice with ethanol and then twice with water. 
Dynamic light scattering (DLS). Size distribution and zeta potential of nanoemulsions and silica 
nanocapsules were determined by DLS using Malvern Zetasizer Nano ZS (Malvern Instrument 
Ltd., Malvern, UK) at a scattering angle of 173° and a temperature of 25 °C. The samples were 
diluted prior to the measurements to avoid multiple scattering effects. 
Transmission electron microscopy (TEM). Morphology of silica nanocapsules was observed by 
TEM using a JEOL 1010 (JEOL, Tokyo, Japan) operated at 100 kV. The silica nanocapsule 
suspensions (2 μL) were deposited onto Formvar-coated copper grids (ProSciTech, Townsville, 
Australia). The size and shell thickness of the silica nanocapsules were analyzed using iTEM 
software (Version 3.2, Soft Imaging System GmbH, Münster, Germany). 
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Reversed-phase high-performance liquid chromatography (RP-HPLC). Concentrations of 
fipronil and D4S2 protein were analyzed using RP-HPLC equipped with a Jupiter C18 column (5 
μm; 300 Å; 150 mm × 4.6 mm) (Phenomenex, Torrance, CA) and connected to an LC-10AVP 
series HPLC system. The mobile phase A was 0.1 v/v% trifluoroacetic acid (TFA) in water, and 
the mobile phase B was 90 v/v% acetonitrile, 0.1 v/v% TFA in water. To measure the concentration 
of fipronil, a linear gradient from 50 to 70% B in 20 min at a flow rate of 1 mL/min with a detection 
wavelength at 220 nm was used. Meanwhile, to determine the concentration of D4S2 protein, a 
linear gradient from 30 to 65% B in 35 min at 1-mL/min flowrate and 214-nm wavelength was 
employed. 
Encapsulation Efficiency. To measure the efficiency of fipronil encapsulation, acetonitrile was 
added to the suspensions of silica nanocapsules to completely extract fipronil from the oil as 
fipronil has high solubility in acetonitrile.24 Then the mixture was centrifuged to obtain the 
supernatant in which the concentration of fipronil was measured using RP-HPLC as described 
above. The encapsulation efficiency (%EE) was calculated as the ratio of the encapsulated amount 
of fipronil compared to the initial amount of fipronil dissolved in Miglyol 812 oil: 
%EE = (1 - 
CsVs
C0V0
) × 100%                                                    (1) 
where Cs (mg/mL) and Vs (mg/mL) are the concentration of fipronil in the supernatant and the 
volume of the supernatant, respectively, and C0 (mg/mL) and V0 (mg/mL) are the initial 
concentration of fipronil in Miglyol 812 oil and the volume of Miglyol 812 oil, respectively. 
In Vitro Release in Water. The release profiles of fipronil from nanoemulsions and silica 
nanocapsules having two different silica-shell thicknesses were investigated in water. The 
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 8 
nanoemulsions and the silica nanocapsule suspensions (containing 200 µg fipronil in 100 µL) were 
each sealed in dialysis tubing (3.5 kDa) in 10 mL water and then shaken at room temperature for 
up to 32 d. At different time intervals, aliquots (200 µL) of the solution outside the dialysis tubing 
were taken and replaced with fresh water. Samples were then analyzed using RP-HPLC to 
determine the concentration of fipronil as described above. 
In Vitro Release at different pHs. The release profiles of fipronil from nanoemulsions and 
silica nanocapsules having thickest shell thickness were studied in water and in solutions of pH 2 
and pH 11. Solutions of pH 2 and pH 11 were obtained by mixing HCl or NaOH with water, 
respectively. The nanoemulsions and the silica nanocapsule suspensions (100 µL) were mixed with 
10 mL water and pH 2- and pH 11-solutions by shaking at room temperature for up to 32 d. At 
different time intervals, aliquots (500 µL) of the suspensions were taken and replaced with fresh 
water and pH 2- and pH 11-solutions. All samples were neutralized to pH 7 by adding 50 µL of 
NaOH (pH 13) or HCl (pH 2) solution prior to fipronil analysis using RP-HPLC. For the 
neutralized silica nanocapsules, fipronil concentrations were examined both in the external 
solution and in the inside silica nanocapsules. To determine the fipronil concentration in the 
external solution, the silica nanocapsule suspension was centrifuged to obtain the supernatant 
which was then directly analyzed by using RP-HPLC. To determine the fipronil concentration 
inside the silica nanocapsules, the precipitates obtained after centrifugation were mixed with 
acetonitrile and then sonicated using ultrasonicator for eight 30 s bursts at 40 W and interspersed 
in an ice bath for 60 s, followed by shaking for 48 h to completely extract fipronil to the bulk 
solutions. Then the mixtures were centrifuged to obtain the supernatants which were subjected to 
RP-HPLC analysis. After 32 d, the silica nanocapsules with different pH treatment were visualized 
by using TEM. 
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In Vitro Release under Simulated Sunlight. The release profiles of fipronil from the 
nanoemulsions and the silica nanocapsules having thickest shell thickness were investigated with 
two different treatments: under a solar simulator (67005 Arc Lamp Housing, Newport Corporation, 
Irvine, CA) at a light intensity of 1000 W/m2 (equivalent to 1 sun) and under a dark condition by 
covering the samples with aluminium foil. The nanoemulsions and silica nanocapsules (100 µL) 
were dispersed in 10 mL water under different radiation conditions at a room temperature for up 
to 72 h. At different time intervals, aliquots (500 µL) of the suspensions were taken, replaced with 
fresh water, and then centrifuged to obtain supernatants (100 µL) which were subjected to fipronil 
analysis using RP-HPLC. On the other hand, the precipitates were resuspended and mixed with 
acetonitrile (500 µL) then sonicated using a Branson Sonifier 450 ultrasonicator for eight 30 s 
bursts at 40 W and interspersed in an ice bath for 60 s, followed by shaking for 48 h. Then samples 
were centrifuged to obtain the supernatants which were analyzed by using RP-HPLC. After 72 h, 
the silica nanocapsules with different radiation treatment were visualized by using TEM. 
RESULTS AND DISCUSSION 
Synthesis and Characterization of Silica Nanocapsules. Silica nanocapsules with tunable 
shell thicknesses were synthesized through an emulsion and biomimetic dual-templating 
technology using dual-functional protein D4S2 (Figure 1). The D4S2 protein was designed in our 
group by modularizing a surface-active module (M(DPSMKQLADS LHQLARQ VSRLEHA)4) 
with a silica mineralization-active module (RKKRKKRKKRKKGGGY). Briefly, fipronil as a 
model sensitive cargo was first dissolved in a pharmaceutical-grade oil Miglyol 812 at a 
concentration of 10 g/L. The fipronil-loaded oil was emulsified in the presence of D4S2 protein 
by sonication. Stable oil-in-water nanoemulsions were thus formed because of the facial 
amphiphilicity of the α-helical surface-active module of D4S2 protein that enabled the 
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 10 
hydrophobic residues of the protein to face and anchor to the oil droplets, while their hydrophilic 
residues projected toward the aqueous phase providing steric and electrostatic stabilization. After 
adding the silica precursor tetraethoxysilane (TEOS) to the nanoemulsions, a silica shell encasing 
the nanoemulsion core was formed through a biosilicification process at pH 7.5 and room 
temperature without using any organic solvents. The biosilicification-active module, which is 
densely packed with cationic amino acid residues as well as polar amino acid residues, oriented 
within the subinterfacial region between nanoemulsion and bulk solution induce the hydrolysis of 
TEOS and the polycondensation of the hydrolyzed TEOS at the oil–water interfaces through 
nucleophilic attack, H-bonding and electrostatic interaction mechanisms,24 hence ultimately 
forming silica shell encapsulating the oil core. 
 
Figure 1. Schematic illustration of the emulsion and biomimetic dual-templating technology for 
the synthesis and use of biomimetic silica nanocapsules as nanocarriers. The fabrication process 
uses dual-functional protein D4S2 for: (i) facilitating the formation and stabilization of a 
nanoemulsion template, and (ii) catalyzing the nucleation and growth of silica at the oil–water 
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interface under near-neutral pH and room temperature without the use of toxic organic solvents. 
The cargo (fipronil) is encapsulated by dissolving it in the oil prior to emulsification. 
Figure 2A shows the size distribution of nanoemulsions (NEs) and silica nanocapsules having 
different shell thicknesses (SNCs-40 and SNCs-77) by using DLS. The hydrodynamic diameter of 
the nanoemulsions was 192 ± 23 nm with a dispersity (Ð) of 0.18 ± 0.02 and a zeta potential of 59 
± 4 mV. The nanoemulsions were then used as templates for the synthesis of silica nanocapsules 
(SNCs-40 and SNCs-77) having a core–shell structure and different silica-shell thicknesses (Figure 
2B,C). The two silica nanocapsules were synthesized by mixing the nanoemulsion templates with 
TEOS at concentrations of 40 and 160 mM that resulted in uniform diameters of 270 ± 19 and 345 
± 13 nm with silica-shell thicknesses of 40 ± 4 and 77 ± 2 nm, respectively, as determined by using 
TEM. In contrast to the nanoemulsions which had a positive zeta potential because of the 
positively-charged D4S2 protein at pH 7.5 present at the oil–water interface, the two silica 
nanocapsules having 40- and 77-nm shell thicknesses showed negative charges of –13 ± 2 and –
33 ± 8 mV, respectively, as a result of the deprotonation of the silanol groups on the silica surface 
(≡Si–O–) at pH 7.5. Furthermore, the encapsulation efficiencies of fipronil in the silica 
nanocapsules of 40 and 77 nm-shells were 96.3 ± 3.5 and 97.5 ± 2.1%, respectively. Compared to 
other approaches for encapsulation, our nanocapsules demonstrated significantly higher 
encapsulation efficiencies.21, 39-40 
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Figure 2. Characterization of fipronil-loaded nanoemulsions (NEs) and fipronil-loaded silica 
nanocapsules having shell thicknesses of 40 (SNCs-40) and 77 (SNCs-77) nm as determined by 
using dynamic light scattering (DLS) and transmission electron microscopy (TEM). (A) Size 
distributions obtained from DLS. (B, C) Morphology of silica nanocapsules having different silica-
shell thicknesses visualized under TEM. 
Effect of Shell Thickness on the Fipronil Release. The effects of silica-shell thickness on the 
release kinetics of fipronil from nanoemulsions and silica nanocapsules were investigated in water 
for a period of 32 d. Figure 3 shows the release profiles of fipronil from nanoemulsions having 
zero silica-shell thickness (NEs) and from silica nanocapsules having shell-thicknesses of 40 
(SNCs-40) and 77 (SNCs-77) nm. Fipronil release from NEs showed a substantially rapid release 
compared to SNCs-40 and SNCs-77, and the release of fipronil from SNCs-77 was slower than 
that of SNCs-40. At 24 h, only 11.5 ± 1.2, 7.6 ± 1.7 and 5.7 ± 1.8% of the total encapsulated 
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fipronil were released from NEs, SNCs-40 and SNCs-77, respectively. The release of fipronil then 
gradually increased with time. At 32 d, 64.6 ± 4.2, 42.0 ± 3.8 and 31.3 ± 3.6% of the initially 
loaded fipronil were released from NEs, SNCs-40 and SNCs-77, respectively. The release rate of 
the three nanosystems in water is in the order of the NEs > SNCs-44 > SNCs-77, demonstrating 
that the silica shell was an effective diffusion barrier in slowing down the release of the 
encapsulated active, and the thicker the shell thickness the slower was the release. The silica 
nanocapsules demonstrated sustained release properties with no indication of initial burst release. 
This is in contrast with other silica nanoparticles which have significant amount of initial burst 
release.41-42  
The release kinetics of fipronil were fitted to different models. It was found that the release of 
fipronil from NEs, SNCs-40 and SNCs-77 can be well described by the Higuchi model (Figure 3): 
𝑄 = 𝑘𝐻 ∙ 𝑡
1/2      (2) 
where Q is the accumulated release of fipronil (%), kH is the Higuchi constant, and t
1/2 is the square 
root of time. Good linear correlations (regression from the Higuchi model; R2 > 0.95) can be 
observed (Figure 3), suggesting that the release of our silica nanocapsules are controlled by 
diffusion. Based on the Higuchi model, the complete release of fipronil can be achieved at 69, 158 
and 286 d for the NEs, SNCs-40 and SNCs-77, respectively, demonstrating a significant role of 
the silica shell in slowing down the release consistent with the experimental results described 
above. We have observed a linear relationship between the shell thickness and the Higuchi constant 
based on the three shell thicknesses (0, 40, and 77 nm) (Figure S1), which may enable us to predict 
the release profiles based on the shell thickness thus achieving purposely designed silica 
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nanocapsules for controlled release. Further experiments will be conducted to confirm the accuracy 
of the correlation. 
 
Figure 3. Release profiles of fipronil from nanoemulsions (NEs) and silica nanocapsules having 
40 (SNCs-40) and 77 (SNCs-77) nm shell thicknesses in water. The dot points and the dotted lines 
represent the experimental data and the nonlinear regression to the Higuchi model, respectively. 
One-way ANOVA was used to determine statistical significance, with P value <0.05 denoted as 
*.Effect of pH on the Fipronil Release. The effects of pH on the release profiles of fipronil from 
the silica nanocapsules having thickest shell thickness (SNCs-77) were investigated in a 32-d 
period. Figure 4 shows the release of fipronil from SNCs-77 in water and in solutions of pH 2 and 
pH 11. As fipronil can be rapidly hydrolyzed at pH 11, the concentration of fipronil inside the 
nanocapsules was measured by first disrupting the core–shell structure of nanocapsules and then 
fipronil released out of the nanocapsules can be neutralized prior to analysis using RP-HPLC. The 
SNCs-77 demonstrated a sustained release of fipronil at all pH conditions. The fipronil release was 
much faster at pH 11 than those at pH 2 and in water, indicating that the silica shell was less stable 
at pH 11. At the end of the 32-d period, the accumulated fipronil release in water and in solutions 
of pH 2 and pH 11 were 35.7 ± 3.9, 56.1 ± 2.5 and 84.8 ± 2.9%, respectively. After 32-d release 
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experiments, the silica nanocapsules were observed by using TEM (Figure 5). The silica 
nanocapsules incubated at pH 2 showed a unique hedgehog-like morphology (Figure 5A), and the 
shell thickness decreased significantly from 77 ± 2 to 26 ± 9 nm, indicating the gradual degradation 
of the silica shell. The silica nanocapsules incubated in water remained slightly intact with a rough 
topology on their surfaces (Figure 5B), and the shell thickness decreased slightly from 77 ± 2 to 
67 ± 6 nm. At pH 11, most silica nanocapsules disintegrated into small silica nanoparticles with a 
diameter ranging from 1 to 20 nm (Figure 5C). All silica nanocapsules incubated at the conditions 
aforementioned demonstrated degradability dependent on solution pH. This is because amorphous 
silica can undergo hydrolysis to soluble silanols (≡Si–OH) by breaking the siloxane bonds (≡Si–
O–Si≡) which is further catalyzed by either acid or alkaline.43 Moreover, the TEM images of the 
silica nanocapsules (Figure 5) corresponded well with the release profiles at three different pHs 
(Figure 4), as the more stable the shell, the slower was the release.  
 
Figure 4. Release profiles of fipronil from the silica nanocapsules having 77 nm-shell in water 
and in solutions of pH 2 and pH 11. 
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Figure 5. Surface morphology of silica nanocapsules having 77 nm-shell after 32 days of 
incubation under different conditions: (A) HCl solution of pH 2; (B) Water; and (C) NaOH solution 
of pH 11. 
Protective Efficacy of Silica Shell against Alkaline Conditions. An effective protection for 
the cargoes encapsulated in nanocarriers is essential as many of the cargoes (e.g., drugs, 
agrochemicals, imaging agents, proteins, and DNAs) are highly sensitive to acidic and/or basic 
conditions during various applications, resulting in degradation hence loss of functionalities. 
Fipronil herein was used as a model sensitive active ingredient, which undergo rapid hydrolysis 
under alkaline conditions to 5-amino-3-carbamoyl-1-(2,6-dichloro-4-(trifluoromethyl)-phenyl)-4-
[(trifluoromethyl)sulfinyl]pyrazole.44 Therefore, the protective efficacy of the silica shell for the 
encapsulated fipronil against degradation was investigated. Silica nanocapsules having 77 nm shell 
thickness (SNCs-77) were used in comparison with the nanoemulsions (NEs) at three different 
conditions i.e., water and solutions of pH 2 and pH 11. Figure 6 shows the variation of Ct/Ct0 (i.e., 
the ratio of the total concentration of fipronil inside and outside (the amount that was released out) 
of either nanoemulsions or nanocapsules to its initial concentration) over 32 d. The Ct/C0 (Figure 
6) represents the degradation rate of fipronil. The total amount of fipronil for both the 
nanoemulsions and the silica nanocapsules remained unchanged in HCl solution of pH 2 (NEs-pH 
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2 and SNCs-77-pH 2) and in water (NEs-Water and SNCs-77-Water), indicating its stability under 
these conditions. However, for the nanoemulsions incubated at pH 11 (NEs-pH 11), the Ct/Ct0 
decreased significantly from 100% to 80.2 ± 3.4% in only 3 h, and then remained declining until 
no fipronil could be detected at day 4, indicating a complete hydrolysis of fipronil. The Ct/C0 vs 
time follows a pseudo-first-order reaction (half-life = 0.83 d): 
r = k ∙ Ct ∙ COH-                                                            (3) 
where r is the hydrolysis rate, k is the second-order constant, Ct is the total concentration of the 
remaining fipronil in the system, and COH
- is the concentration of hydroxide ion. The COH
- is 
considered as a constant in this study, therefore the hydrolysis rate becomes: 
r = k' ∙ Ct                                                                (4) 
where k' is the pseudo-first order constant, making the hydrolysis process a pseudo-first-order 
reaction. In comparison, fipronil in the silica nanocapsules with a shell thickness of 77 nm at pH 
11 (SNCs-77-pH 11) demonstrated a much slower degradation rate (Figure 6). At 32 d there was 
still 15.3 ± 2.9%, revealing that the half-life of fipronil encapsulated in the silica nanocapsules at 
pH 11 had been prolonged by approximately 11 times, i.e., 0.83 d for the nanoemulsions (NEs-pH 
11) and 8.93 d for the silica nanocapsules (SNCs-77-pH 11). These results demonstrated a 
remarkable protective efficacies of the silica shell for fipronil against degradation under alkaline 
conditions in comparison to the nanoemulsions which do not have silica shell. In contrast to other 
materials which rely on adsorption of cargoes on the surface or porous structure,21, 39, 41 our silica 
nanocapsules can retain most cargo in the oil core, as indicated by the absence of initial burst 
release (Figures 3 and 5), thus prolonging the lifetime of those active ingredients which are prone 
to undergo degradation. 
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Figure 6. Effect of pHs on the degradation kinetics of fipronil encapsulated in nanoemulsions and 
silica nanocapsules having 77 nm-shell. Variation of the total fipronil amount remained in the 
nanoemulsion and silica nanocapsules in water (NEs-Water and SNCs-77-Water) and in solutions 
of pH 2 (NEs-pH 2 and SNCs-77-pH 2) and pH 11 (NEs-pH 11 and SNCs-77-pH 11) are presented. 
Protective Efficacy of Silica Shell against Sunlight. Driven by the fact that many active 
ingredients, such as ibuprofen,45 darbepoetin-α,46 vinclozolin,47 and hydramethylnon,48 are light 
sensitive and thus require a great care during long-term storage, we also investigated the efficacies 
of silica nanocapsules for protection of encapsulated actives against light. Fipronil encapsulated in 
silica nanocapsules having 77 nm-shell was used in this study as it is also sensitive to light hence 
prone to undergo photolysis.44 A solar simulator (1000 W/m2, equivalent to 1 sun intensity) was 
used to mimic natural sunlight. Figure 7 shows the variation of Ct/C0 (i.e., the ratio of the total 
concentration of fipronil inside and outside the nanoemulsions or nanocapsules to its initial 
concentration) under light exposure and dark condition over a 72-h period. The Ct/C0 (Figure 7) 
represents the degradation rate of fipronil under the light. The total concentrations of fipronil 
remained unchanged under dark condition for both the nanoemulsions (NEs-D) and silica 
nanocapsules (SNCs-77-D). However, the concentrations of fipronil in the nanoemulsions under 
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light (NEs-L) decreased dramatically to 68.9 ± 4.1% at 1.13 h, and it was completely degraded at 
9 h. The degradation of fipronil followed a first-order reaction model with a degradation half-life 
of 2.27 h. In contrast, the concentrations of fipronil in the silica nanocapsules under light exposure 
(SNCs-77-L) demonstrated a much slower degradation with 95.4 ± 3.2 and 83.9 ± 0.3% fipronil 
remaining at 1.13 and 9 h, respectively. At the end of the 72 h light-exposure experiment, 61.5 ± 
1.0% of the total fipronil was still present. The results demonstrated that the silica shell provided 
an excellent sunlight-shielding ability and thus protected the light-sensitive fipronil from photo-
degradation. 
 
Figure 7. Effect of light exposure (1000 W/m2) on the degradation kinetics of fipronil encapsulated 
in nanoemulsions and silica nanocapsules having 77 nm-shell. Variation of the total fipronil 
amount remained in the nanoemulsions and silica nanocapsules over 72 h of incubation under light 
irradiation (NEs-L and SNCs-77-L) and dark condition (NEs-D and SNCs-77-D) are presented. 
The concentrations of fipronil inside the silica nanocapsules were calculated and compared 
under light exposure and dark condition to determine whether fipronil inside the nanocapsules 
remained intact. Figure 8A shows the variation of Ci/C0 (i.e., the ratio of the fipronil concentration 
inside the silica nanocapsules to its initial concentration) under simulated light and dark conditions 
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over a 72-h period. The silica nanocapsules under dark condition (In-SNCs-77-D) showed a 
sustained release of fipronil with 87.1 ± 1.4% of the fipronil remained inside the nanocapsules at 
72 h. In contrast, the concentration of fipronil inside the silica nanocapsules under light (In-SNCs-
77-L) decreased more rapidly i.e., 61.5 ± 1.0% at 72 h. This result indicated that the silica shell 
provided certain level of protection against light degradation, as silica is optically transparent,49 
and the protection efficacy was around 70.6% (=61.5/87.1). Figure 8B shows the variation of the 
Ce/C0 (i.e., the ratio of the fipronil concentration in the external buffer solution to the initial 
concentration) under both dark and light conditions over a 72-h period. It is clear that fipronil was 
released gradually from the silica nanocapsules that incubated under dark condition (Ex-SNCs-77-
D). As expected, no fipronil can be detected for those silica nanocapsules incubated under light 
condition (Ex-SNCs-77-L). This is because once fipronil released from the silica nanocapsules it 
exposed to the light and underwent rapid photo-degradation. 
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Figure 8. Efficacies of silica nanocapsules for the protection of the encapsulated fipronil against 
light exposure (1000 W/m2). (A) Variation of the fipronil concentrations in the dispersed phase 
(inside the silica shell) of the silica nanocapsules having 77 nm-shell with (In-SNCs-77-L) and 
without (In-SNCs-77-D) light irradiation. (B) Variation of the fipronil concentrations in the 
continuous phase (outside the silica shell) of the silica nanocapsules having 77 nm-shell with (Ex-
SNCs-77-L) and without (Ex-SNCs-77-D) light irradiation. 
The physicochemical properties (size, size distribution, zeta potential and surface morphology) 
of nanoemulsions and silica nanocapsules having 77 nm-shell after 72 h-incubation under light 
(1000 W/m2) were further examined. Figure 9A shows the DLS results of nanoemulsions and silica 
nanocapsules before and after exposure to light. The nanoemulsions exhibited a significant size 
Page 21 of 29
ACS Paragon Plus Environment
Langmuir
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 22 
increase from 192 ± 23 nm before the irradiation (NEs-BF-L) to 510 ± 43 nm after the irradiation 
(NEs-AT-L), whereas no difference was observed for the silica nanocapsules before (SNCs-77-
BF-L) and after (SNCs-77-AT-L) the irradiation (Figure 9A). The Ð of the nanoemulsions also 
experienced a sharp increase (from 0.18 ± 0.02 to 0.63 ± 0.04) after the irradiation. This result 
indicate that the protein covering the nanoemulsion may undergo structural changes under light 
exposure50 which caused irreversible aggregation of the nanoemulsions. In contrast, the Ð of the 
silica nanocapsules remained relatively unchanged. The zeta potential of the nanoemulsions 
changed from 59 ± 4 to –12 ± 5 mV after irradiation, while the silica nanocapsules showed a stable 
zeta potential of –33 ± 8 mV during the 72 h-incubation. Furthermore, the TEM images show 
intact core–shell structure of the silica nanocapsules with good dispersity after 72 h of light 
exposure (Figure 9B), consistent with the DLS results (Figure 9A). These results demonstrated the 
excellent stability of the silica nanocapsules against sunlight irradiation, unlike nanoemulsions. 
 
Figure 9. Effect of light exposure (1000 W/m2, 72 h) to the physicochemical properties of 
nanoemulsions and silica nanocapsules having 77 nm-shell as determined by using dynamic light 
scattering (DLS) and transmission electron microscopy (TEM). (A) Size distribution of 
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nanoemulsions and silica nanocapsules before (NEs-BF-L and SNCs-77-BF-L) and after (NEs-
AT-L and SNCs-77-AT-L) light irradiation. (B) Structure of silica nanocapsules after light 
irradiation (SNCs-77-AT-L). 
CONCLUSIONS 
Biocompatible silica nanocapsules having an oil-core silica shell structure with different shell 
thicknesses of 40 and 77 nm were synthesized using an emulsion-biosilicification dual-templating 
technology, and high encapsulation efficiencies (96.3 and 97.5%) were achieved. The release 
studies demonstrated an inverse relationship between the shell thickness and the release rate, and 
the release profiles fitted well to the Higuchi model. The silica nanocapsules showed different 
release kinetics under three conditions (water and solutions of pH 2 and pH 11) with accumulated 
release rates of 35.7, 56.1 and 84.8%, respectively, after 32 d of incubation. In addition to the 
fipronil release, the pH of the solutions where nanocapsules were dispersed influenced the 
degradation of silica. The silica shell degraded slightly in water but experienced significant 
changes at pH 2 and pH 11. Especially for pH 11, the silica nanocapsules disintegrated into small 
nanoparticles after 32 d. However, compared to the nanoemulsions, the silica nanocapsules showed 
excellent protection of the encapsulated fipronil against degradation at pH 11 as the half-life of 
fipronil within the nanocapsules was prolonged by approximately 11 times. Furthermore, silica 
nanocapsules demonstrated a 70.6% protection efficiency for the encapsulated fipronil after 72-h 
irradiation to simulated sunlight (1000 W/m2). In contrast, the fipronil loaded in the nanoemulsions 
experienced complete degradation within 9 h. This work systematically investigated the release 
properties of our silica nanocapsules under different pH and light conditions, providing a 
fundamental understanding of this unique nanosystem for potential applications in controlled 
release. 
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A, alanine; D, aspartic acid; DLS, dynamic light scattering; E, glutamic acid; EE, encapsulation 
efficiency; G, glycine; H, histidine; HEPES, 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic 
acid; K, lysine; L, leucine; M, methionine; MW, molecular weight; NEs, nanoemulsions; P, proline; 
Q, glutamine; R, arginine; RP-HPLC, reversed-phase high-performance liquid chromatography; 
S, serine; SNCs, silica nanocapsules; TEM, transmission electron microscopy; TEOS, 
tetraethoxysilane; TFA, trifluoroacetic acid; V, valine; Y, tyrosine; Ð, dispersity. 
REFERENCES 
(1) Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery. ACS Nano 
2009, 3 (1), 16-20. 
(2) Dasgupta, N.; Ranjan, S.; Mundekkad, D.; Ramalingam, C.; Shanker, R.; Kumar, A. 
Nanotechnology in Agro-Food: from Field to Plate. Food Res. Int. 2015, 69, 381-400. 
(3) Kaur, I. P.; Agrawal, R. Nanotechnology: a New Paradigm in Cosmeceuticals. Recent Pat. 
Drug Delivery Formulation 2007, 1 (2), 171-182. 
(4) Nielsen, P. E.; LEICK, V.; Buchardt, O. Light Sensitive Chloramphenicol Analogues. Acta 
Chem. Scand., Ser. B 1975, 29, 662-66. 
(5) Eggeling, C.; Widengren, J.; Rigler, R.; Seidel, C. Photobleaching of Fluorescent Dyes 
under Conditions Used for Single-Molecule Detection: Evidence of Two-Step Photolysis. Anal. 
Chem. 1998, 70 (13), 2651-2659. 
(6) Vikram, V.; Ramesh, M.; Prapulla, S. Thermal Degradation Kinetics of Nutrients in 
Orange Juice Heated by Electromagnetic and Conventional Methods. J. Food Eng. 2005, 69 (1), 
31-40. 
(7) Katsumata, H.; Okada, T.; Kaneco, S.; Suzuki, T.; Ohta, K. Degradation of Fenitrothion 
by Ultrasound/Ferrioxalate/UV System. Ultrason. Sonochem. 2010, 17 (1), 200-206. 
(8) Sköld, M.; Karlberg, A.-T.; Matura, M.; Börje, A. The Fragrance Chemical β-
Caryophyllene—Air Oxidation and Skin Sensitization. Food Chem. Toxicol. 2006, 44 (4), 538-
545. 
(9) Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. 
Biodegradable Long-Circulating Polymeric Nanospheres. Science 1994, 263 (5153), 1600-1603. 
(10) Stuart, M. A. C.; Huck, W. T.; Genzer, J.; Müller, M.; Ober, C.; Stamm, M.; Sukhorukov, 
G. B.; Szleifer, I.; Tsukruk, V. V.; Urban, M. Emerging Applications of Stimuli-Responsive 
Polymer Materials. Nat. Mater. 2010, 9 (2), 101-113. 
(11) Soppimath, K. S.; Aminabhavi, T. M.; Kulkarni, A. R.; Rudzinski, W. E. Biodegradable 
Polymeric Nanoparticles as Drug Delivery Devices. J. Controlled Release 2001, 70 (1), 1-20. 
(12) MuÈller, R. H.; MaÈder, K.; Gohla, S. Solid Lipid Nanoparticles (SLN) for Controlled 
Drug Delivery–a Review of the State of the Art. Eur. J. Pharm. Biopharm. 2000, 50 (1), 161-177. 
(13) Mehnert, W.; Mäder, K. Solid Lipid Nanoparticles: Production, Characterization and 
Applications. Adv. Drug Delivery Rev. 2001, 47 (2), 165-196. 
Page 25 of 29
ACS Paragon Plus Environment
Langmuir
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 26 
(14) Wissing, S.; Kayser, O.; Müller, R. Solid Lipid Nanoparticles for Parenteral Drug Delivery. 
Adv. Drug Delivery Rev. 2004, 56 (9), 1257-1272. 
(15) Cushing, B. L.; Kolesnichenko, V. L.; O'Connor, C. J. Recent Advances in the Liquid-
Phase Syntheses of Inorganic Nanoparticles. Chem. Rev. 2004, 104 (9), 3893-3946. 
(16) Daniel, M.-C.; Astruc, D. Gold Nanoparticles: Assembly, Supramolecular Chemistry, 
Quantum-Size-Related Properties, and Applications toward Biology, Catalysis, and 
Nanotechnology. Chem. Rev. 2004, 104 (1), 293-346. 
(17) Lai, C.-Y.; Trewyn, B. G.; Jeftinija, D. M.; Jeftinija, K.; Xu, S.; Jeftinija, S.; Lin, V. S.-Y. 
A Mesoporous Silica Nanosphere-Based Carrier System with Chemically Removable CdS 
Nanoparticle Caps for Stimuli-Responsive Controlled Release of Neurotransmitters and Drug 
Molecules. J. Am. Chem. Soc. 2003, 125 (15), 4451-4459. 
(18) Torney, F.; Trewyn, B. G.; Lin, V. S.-Y.; Wang, K. Mesoporous Silica Nanoparticles 
Deliver DNA and Chemicals into Plants. Nat. Nanotechnol. 2007, 2 (5), 295-300. 
(19) Lou, X. W. D.; Archer, L. A.; Yang, Z. Hollow Micro‐/Nanostructures: Synthesis and 
Applications. Adv. Mater. 2008, 20 (21), 3987-4019. 
(20) Wibowo, D.; Hui, Y.; Middelberg, A. P.; Zhao, C.-X. Interfacial Engineering for Silica 
Nanocapsules. Adv. Colloid Interface Sci. 2016. 
(21) Chen, J.-F.; Ding, H.-M.; Wang, J.-X.; Shao, L. Preparation and Characterization of Porous 
Hollow Silica Nanoparticles for Drug Delivery Application. Biomaterials 2004, 25 (4), 723-727. 
(22) Wang, Y.; Wang, K.; Zhang, R.; Liu, X.; Yan, X.; Wang, J.; Wagner, E.; Huang, R. 
Synthesis of Core–Shell Graphitic Carbon@ Silica Nanospheres with Dual-Ordered Mesopores 
for Cancer-Targeted Photothermochemotherapy. ACS Nano 2014, 8 (8), 7870-7879. 
(23) Chang, F.-P.; Hung, Y.; Chang, J.-H.; Lin, C.-H.; Mou, C.-Y. Enzyme Encapsulated 
Hollow Silica Nanospheres for Intracellular Biocatalysis. ACS Appl. Mater. Interfaces 2014, 6 (9), 
6883-6890. 
(24) Wibowo, D.; Zhao, C.-X.; Middelberg, A. P. Emulsion-Templated Silica Nanocapsules 
Formed Using Bio-Inspired Silicification. Chem. Commun. 2014, 50 (77), 11325-11328. 
(25) Rana, R. K.; Mastai, Y.; Gedanken, A. Acoustic Cavitation Leading to the 
Morphosynthesis of Mesoporous Silica Vesicles. Adv. Mater. 2002, 14 (19), 1414-1418. 
(26) Wang, J.-G.; Li, F.; Zhou, H.-J.; Sun, P.-C.; Ding, D.-T.; Chen, T.-H. Silica Hollow 
Spheres with Ordered and Radially Oriented Amino-Functionalized Mesochannels. Chem. Mater. 
2009, 21 (4), 612-620. 
(27) Kröger, N.; Deutzmann, R.; Sumper, M. Polycationic peptides from diatom biosilica that 
direct silica nanosphere formation. Science 1999, 286 (5442), 1129-1132. 
(28) Luckarift, H. R.; Spain, J. C.; Naik, R. R.; Stone, M. O. Enzyme immobilization in a 
biomimetic silica support. Nat. Biotechnol. 2004, 22 (2), 211-213. 
(29) Yokoi, T.; Sakamoto, Y.; Terasaki, O.; Kubota, Y.; Okubo, T.; Tatsumi, T. Periodic 
arrangement of silica nanospheres assisted by amino acids. J. Am. Chem. Soc. 2006, 128 (42), 
13664-13665. 
(30) Yuan, J.-J.; Mykhaylyk, O. O.; Ryan, A. J.; Armes, S. P. Cross-linking of cationic block 
copolymer micelles by silica deposition. J. Am. Chem. Soc. 2007, 129 (6), 1717-1723. 
(31) Tomczak, M. M.; Glawe, D. D.; Drummy, L. F.; Lawrence, C. G.; Stone, M. O.; Perry, C. 
C.; Pochan, D. J.; Deming, T. J.; Naik, R. R. Polypeptide-templated synthesis of hexagonal silica 
platelets. J. Am. Chem. Soc. 2005, 127 (36), 12577-12582. 
Page 26 of 29
ACS Paragon Plus Environment
Langmuir
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 27 
(32) Jakhmola, A.; Vecchione, R.; Guarnieri, D.; Belli, V.; Calabria, D.; Netti, P. A. Bioinspired 
Oil Core/Silica Shell Nanocarriers with Tunable and Multimodal Functionalities. Adv. Healthcare 
Mater. 2015, 4 (17), 2688-2698. 
(33) Erni, P.; Dardelle, G.; Sillick, M.; Wong, K.; Beaussoubre, P.; Fieber, W. Turning 
coacervates into biohybrid glass: Core/shell capsules formed by silica precipitation in 
protein/polysaccharide scaffolds. Angew. Chem. 2013, 125 (39), 10524-10528. 
(34) Wibowo, D.; Zhao, C.-X.; Middelberg, A. P. Interfacial Biomimetic Synthesis of Silica 
Nanocapsules Using a Recombinant Catalytic Modular Protein. Langmuir 2015, 31 (6), 1999-
2007. 
(35) Chen, Y.; Kang, E.-T.; Neoh, K.-G.; Greiner, A. Preparation of Hollow Silica Nanospheres 
by Surface‐Initiated Atom Transfer Radical Polymerization on Polymer Latex Templates. Adv. 
Funct. Mater. 2005, 15 (1), 113-117. 
(36) Zhao, W.; Lang, M.; Li, Y.; Li, L.; Shi, J. Fabrication of Uniform Hollow Mesoporous 
Silica Spheres and Ellipsoids of Tunable Size Through a Facile Hard-Templating Route. J. Mater. 
Chem. 2009, 19 (18), 2778-2783. 
(37) Wibowo, D.; Yang, G.-Z.; Middelberg, A. P. J.; Zhao, C.-X. Non-Chromatographic 
Bioprocess Engineering of a Recombinant Mineralizing Protein for the Synthesis of Silica 
Nanocapsules. Biotechnol. Bioeng. 2016, n/a-n/a. 
(38) Kasai, A.; Hayashi, T. I.; Ohnishi, H.; Suzuki, K.; Hayasaka, D.; Goka, K. Fipronil 
application on rice paddy fields reduces densities of common skimmer and scarlet skimmer. Sci. 
Rep. 2016, 6. 
(39) Li, Z.-Z.; Wen, L.-X.; Shao, L.; Chen, J.-F. Fabrication of porous hollow silica 
nanoparticles and their applications in drug release control. J. Controlled Release 2004, 98 (2), 
245-254. 
(40) Mahony, D.; Cavallaro, A.; Mody, K.; Xiong, L.; Mahony, T.; Qiao, S.; Mitter, N. In vivo 
delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles. 
Nanoscale 2014, 6 (12), 6617-6626. 
(41) Li, Z.-Z.; Xu, S.-A.; Wen, L.-X.; Liu, F.; Liu, A.-Q.; Wang, Q.; Sun, H.-Y.; Yu, W.; Chen, 
J.-F. Controlled Release of Avermectin from Porous Hollow Silica Nanoparticles: Influence of 
Shell Thickness on Loading Efficiency, UV-Shielding Property and Release. J. Controlled Release 
2006, 111 (1), 81-88. 
(42) Goscianska, J.; Olejnik, A.; Nowak, I.; Marciniak, M.; Pietrzak, R. Ordered Mesoporous 
Silica Modified with Lanthanum for Ibuprofen Loading and Release Behaviour. Eur. J. Pharm. 
Biopharm. 2015, 94, 550-558. 
(43) Brinker, C. J. Hydrolysis and condensation of silicates: Effects on structure. Journal of 
Non-Crystalline Solids 1988, 100 (1), 31-50. 
(44) Bobé, A.; Meallier, P.; Cooper, J.-F.; Coste, C. M. Kinetics and Mechanisms of Abiotic 
Degradation of Fipronil (Hydrolysis and Photolysis). J. Agric. Food Chem. 1998, 46 (7), 2834-
2839. 
(45) Li, F. H.; Yao, K.; Lv, W. Y.; Liu, G. G.; Chen, P.; Huang, H. P.; Kang, Y. P. 
Photodegradation of Ibuprofen under UV–Vis Irradiation: Mechanism and Toxicity of Photolysis 
Products. Bull. Environ. Contam. Toxicol. 2015, 94 (4), 479-483. 
(46) Kerwin, B. A.; Remmele, R. L. Protect from Light: Photodegradation and Protein 
Biologics. J. Pharm. Sci. 2007, 96 (6), 1468-1479. 
(47) Samanta, S.; Kole, R.; Chowdhury, A. Photodegradation of Metsulfuron Methyl in 
Aqueous Solution. Chemosphere 1999, 39 (6), 873-879. 
Page 27 of 29
ACS Paragon Plus Environment
Langmuir
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 28 
(48) Burrows, H. D.; Santaballa, J.; Steenken, S. Reaction Pathways and Mechanisms of 
Photodegradation of Pesticides. J. Photochem. Photobiol., B 2002, 67 (2), 71-108. 
(49) Zhou, S.; Wu, L. Transparent organic–inorganic nanocomposite coatings. Functional 
Polymer Coatings: Principles, Methods, and Applications 2015, 12, 1. 
(50) Kristo, E.; Hazizaj, A.; Corredig, M. Structural changes imposed on whey proteins by UV 
irradiation in a continuous UV light reactor. J. Agric. Food Chem. 2012, 60 (24), 6204-6209. 
  
Page 28 of 29
ACS Paragon Plus Environment
Langmuir
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 29 
TABLE OF CONTENT GRAPHIC 
 
Page 29 of 29
ACS Paragon Plus Environment
Langmuir
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
